Ethical review process and outcomes | All studies | Studies involving minority groups | ||||||
---|---|---|---|---|---|---|---|---|
Clinical studies | Non-clinical studies | Clinical studies | Non-clinical studies | |||||
Initial review | Continuing review | Initial review | Continuing review | Without extra-vulnerable minority | With extra-vulnerable minority | Without extra-vulnerable minority | With extra-vulnerable minority | |
N = 96 | N = 43 | N = 195 | N = 39 | N = 19 | N = 14 | N = 4 | N = 7 | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Type of review | ||||||||
Full board | 96 (100%) | 11 (25.6%) | 129 (66.1%) | 1 (2.6%) | 19 (100%) | 14 (100%) | 4 (100%) | 7 (100%) |
Expedited | 0 | 32 (74.4%) | 59 (30.3%) | 38 (97.4%) | 0 | 0 | 0 | 0 |
Exempted | 0 | 0 | 7 (3.6%) | 0 | 0 | 0 | 0 | 0 |
Initial review outcome | ||||||||
Simple approval | 0 | 27 (62.8%) | 13 (6.7%) | 38 (97.4%) | 0 | 0 | 0 | 0 |
Approval after clarification/revision | 92 (96%) | 13 (30.2%) | 176 (90.2%) | 0 | 17 (89.4%) | 12 (86%) | 3 (75%) | 7 (100%) |
Deferment | 3 (3%) | 0 (0%) | 5 (2.6%) | 0 | 1 (5.3%) | 1 (7%) | 0 | 0 |
Non-approval | 1 (1%) | 3 (7%) | 1 (0.5%) | 1 (2.6%) | 1 (5.3%) | 1 (7%) | 1 (25%) | 0 |